Wound Closure Devices Market Report 2025

The wound closure devices market size has grown strongly in recent years. It will grow from $16.68 billion in 2024 to $17.94 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing surgical procedures, growing aging population, prevalence of chronic diseases, rise in traumatic injuries, shift to minimally invasive surgeries, patient preference for aesthetic closure, hospital and ambulatory care settings.

The wound closure devices market size is expected to see strong growth in the next few years. It will grow to $25.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to patient safety and infection control, telemedicine and remote wound care, biodegradable closure devices, home healthcare and self-care, global health emergency preparedness, expansion of outpatient procedures, value-based healthcare models. Major trends in the forecast period include rise in minimally invasive wound closure techniques, focus on accelerated wound healing, growing demand for hemostats and sealants, shift toward disposable wound closure devices, regulatory initiatives for patient safety.

The rising number of patients undergoing surgeries is anticipated to drive the growth of the wound closure devices market in the future. Surgery is a medical specialty that involves manual and instrumental procedures performed on an individual to evaluate or treat a pathological condition, such as an illness or injury, to improve body function and appearance, or to repair unwanted ruptured areas. Wound closure devices are utilized to address chronic, traumatic, and surgical wounds, as well as skin grafts and flaps. For example, in June 2024, a report by the International Society of Aesthetic Plastic Surgery, a US-based organization for board-certified aesthetic plastic surgeons, indicated that total surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million. Procedures involving the face and head experienced substantial growth, totaling over 6.5 million, with a 19.6% rise from the previous year. Notable procedures included eyelid surgeries, with more than 1.7 million and a 24% increase, rhinoplasty with 1.1 million procedures and a 21.6% rise, and lip enhancement/perioral procedures, which grew by 29% to 0.9 million. Consequently, the growing number of patients undergoing surgeries is fueling the expansion of the wound closure devices market.

The rising prevalence of diabetes is projected to drive the growth of the wound closure devices market in the coming years. Diabetes, known as diabetes mellitus, is a chronic medical condition that impacts how the body processes glucose (sugar), which is a vital energy source. Wound closure devices play a significant role in diabetes management by facilitating effective healing and minimizing the risk of complications. Properly closing wounds can help prevent the onset of chronic ulcers and other diabetes-related issues, ultimately enhancing the overall health and quality of life for individuals with the condition. For example, data published by the American Diabetes Association in June 2022 indicated that 37.3 million people in the U.S. have diabetes, accounting for 11.3% of the population. Therefore, the increasing prevalence of diabetes is contributing to the growth of the wound closure devices market.

Technological advancements are a significant trend gaining traction in the wound closure devices market. Leading companies in this sector are concentrating on developing innovative technological solutions that are adaptable across various elements to secure a competitive advantage. For example, in October 2023, DuPont, a U.S.-based chemicals firm, introduced the DuPont Liveo MG 7-9960 Soft Skin Adhesive. This formulation is designed to be non-sensitizing and non-irritating, making it suitable for sensitive skin, including that of children, the elderly, and patients with skin conditions or open wounds. The adhesive allows for the repositioning of devices without compromising effectiveness, which is essential in medical environments where adjustments may be required. It offers gentle adhesion for dressings applied to wounds, ensuring they remain securely in place while enabling easy removal without causing skin trauma.

Major companies are strategically forming partnerships and collaborations with start-ups and mid-sized firms in the wound closure devices market to enhance their range of products and services. These strategic alliances and partnership agreements enable companies to broaden their existing product portfolios and expand their geographical reach. For example, in April 2022, KitoTech Medical, a Seattle-based medical device company, established a partnership and signed an exclusive agreement with U.S.-based Corza Medical, a manufacturer of innovative surgical technologies. This agreement grants KitoTech the rights to market and sell the microMend family of wound closure products in the medical and surgical sectors. Through this collaboration, Corza aims to deliver exceptional value to customers with high-quality products, including barbed and traditional sutures, providing clinicians with an innovative wound closure technology for their patients.

In October 2024, Mölnlycke Health Care, a medical device company based in Sweden, acquired P.G.F. Industry Solutions GmbH for an undisclosed sum. This acquisition enables Mölnlycke to broaden its wound care offerings, specifically by incorporating the Granudacyn range, which consists of solutions for wound cleansing and moisturizing. P.G.F. Industry Solutions GmbH is an Austria-based company that focuses on providing solutions for wound management, particularly through its diverse product range.

Major companies operating in the wound closure devices market are Abbott Laboratories, Advanced Medical Solutions Group PLC, Arthrex Inc., B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, BSN Medical GmbH, Chemence Medical Inc., Coloplast A/S, ConvaTec Group PLC, CryoLife Inc., Dach Medical Group Holding AG, DeRoyal Industries Inc., Futura Surgicare Private Limited, Healthium Medtech Private Limited, Integra LifeSciences Corporation, IVT Medical Limited, Johnson & Johnson Services Inc., Meril Life Sciences Private Limited, 3M Company, Adhezion Biomedical LLC, Becton, Dickinson and Company, Medtronic Inc., Halyard Health Inc., McKesson Corp., Medline Industries LP, Molnlycke Health Care Ltd., Myco Medical Supplies Inc., Nexus Medical Ltd., Smith & Nephew PLC, Smiths Group PLC, Stryker Corp., Teleflex Inc., Wound Care Technologies Inc., Zipline Medical Inc.

North America was the largest region in the wound closure devices market in 2024. The regions covered in the wound closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wound closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Wound closure devices are mechanical tools designed for internal consistency, reliability, and functionality to aid in the closure of wounds by bringing together tissue margins. These devices play a crucial role in stopping bleeding, preventing infection, accelerating healing, and preserving the aesthetic and functional aspects of the injured area.

The primary types of wound closure devices include adhesives, staples, sutures, strips, sealants, and mechanical wound closure devices. Adhesives are substances capable of holding materials together through surface attachment, resisting separation in a functional manner. Wound closure devices are applied to different types of wounds, categorized as chronic and acute. Various end-users, including hospitals, clinics, trauma centers, and other healthcare facilities, utilize these devices in the process of wound closure.

The wound closure devices market research report is one of a series of new reports that provides wound closure devices market statistics, including wound closure devices industry global market size, regional shares, competitors with a wound closure devices market share, detailed wound closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the wound closure devices industry. This wound closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The wound closure devices market consists of sales of hemostatic agents and ligating clips. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.